Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06290765
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-04
First Post:
2024-01-26
Brief Title:
Efficacy and Safety of Ropeginterferon Alfa 2b P1101 for Patients With Low-Risk Polycythemia Vera
Sponsor:
PharmaEssentia
Organization:
PharmaEssentia
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-26
First Submit QC Date:
February 29 2024
Study First Post Date:
2024-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-29
Last Update Post Date:
2024-03-04
Last Update Post Date Type:
ACTUAL